Controversies

Regulator orders recall and sales suspension of 'Caelyx' and 'Velcade'

Because the US BVL factory of the imported-drug manufacturer had deficiencies in aseptic filling quality management, the State Food and Drug Administration required Xian Janssen to recall the anticancer drug 'Caelyx' and suspend sales of 'Velcade'; the company called it a preventive recall and insisted there was no quality problem. Product recall and sales suspension.